Thymalin (25mg) Research Peptide: A Polypeptide Complex for Immunomodulation, Geroprotection & Stem Cell Differentiation Studies
If your research investigates immune regulation, T‑cell differentiation, or the molecular mechanisms of hematopoietic stem cell activation, Thymalin (25mg) research peptide — also known as Thymalin® — offers a precisely defined polypeptide complex with a well‑established scientific pedigree. Thymalin is a natural polypeptide complex originally isolated from the thymus gland of young calves, developed in the 1970s by Vladimir Khavinson and Vyacheslav Morozov at the Military Medical Academy in Leningrad (now Saint Petersburg), Russia. It was the first in a class of compounds Khavinson termed “peptide bioregulators” — short‑chain peptides proposed to restore organ function through direct interaction with gene regulatory elements.
The preparation contains a mixture of low‑molecular‑weight peptides (up to 10 kDa), with three principal bioactive components identified: the dipeptide L‑Glu‑L‑Trp (EW, later synthesised independently as the drug Thymogen), the dipeptide Lys‑Glu (KE, marketed as Vilon), and the tripeptide Glu‑Asp‑Pro (EDP, known as Crystagen). Thymalin has been shown to normalise T‑ and B‑lymphocyte ratios, stimulate cellular immunity, increase phagocytosis, facilitate regeneration, and enhance haematopoiesis. By epigenetically regulating gene expression and protein synthesis involved in immunogenesis, Thymalin activates haematopoietic stem cell differentiation into CD28+ T‑lymphocytes during immune suppression. This makes Thymalin (25mg) research peptide a valuable tool for laboratories investigating immunology, gerontology, haematopoiesis, and infectious disease models.
At Chinese Grey Peptides, we supply high‑purity Thymalin (25mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to high purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into immune regulation, stem cell biology, and geroprotection begin with uncompromising quality.
What Is Thymalin and How Does It Work?
To fully appreciate the research potential of Thymalin (25mg) research peptide, it is essential to understand its biochemical composition and the mechanisms by which it exerts its pleiotropic effects.
The Thymic Polypeptide Complex
Thymalin is a polypeptide complex derived from the thymus gland (of bovine calf origin), containing a mixture of low‑molecular‑weight peptides and free amino acids with molecular weights ranging from 1,000 to 10,000 Da. Unlike single‑entity pharmaceuticals, Thymalin is a multi‑component preparation, though its biological activity has been attributed primarily to three identified short peptides:
| Component | Sequence | Key Research Properties |
|---|---|---|
| EW (Thymogen) | Glu‑Trp | Activates T‑cell differentiation, modulates cyclic nucleotide balance (cAMP/cGMP), enhances neutrophil chemotaxis and phagocytosis |
| KE (Vilon) | Lys‑Glu | Stimulates cellular immunity and non‑specific resistance; activates macrophages, blood lymphocytes, thymocytes, and neutrophils |
| EDP (Crystagen) | Glu‑Asp‑Pro | Regulates gene expression and protein synthesis involved in immunogenesis and apoptosis |
The most pharmacologically characterised of these is the EW dipeptide (Thymogen), with molecular formula C₁₆H₁₉N₃O₅ and molecular weight 333.34 g/mol.
Mechanism of Action: Epigenetic Regulation and Immune Modulation
The biological activity of Thymalin (25mg) research peptide is mediated through several intersecting mechanisms:
Epigenetic Gene Regulation via DNA and Histone Binding
Thymalin belongs to the group of drugs that epigenetically regulate gene expression and synthesis of immunogenesis proteins. The short peptides EW, KE, and EDP in the composition of Thymalin are able to complementarily bind to certain DNA sequences or histone proteins. As a result of this binding, there is a change in gene expression and synthesis of heat‑shock proteins, cytokines, fibrinolysis system components, gerontogenes, and proteins involved in the differentiation, proliferation, and apoptosis of immune cells.
Normalisation of Lymphocyte Differentiation and Proliferation
Thymalin normalises differentiation, proliferation, and reduces apoptosis of lymphoid cells. It restores the number and ratio of T‑ and B‑lymphocytes and their subpopulations, stimulates cellular immunity response, increases phagocytosis, facilitates the processes of regeneration and haematopoiesis in cases of suppression, and enhances the processes of cell metabolism. The immunoprotective effect of Thymalin is expressed in the restoration of the number and ratio of T and B lymphocytes, their subpopulations, an increase in their functional activity, and increased phagocytosis.
Hematopoietic Stem Cell Differentiation
Thymalin increases functional activity of T lymphocytes. It activates haematopoietic stem cell (HSC) differentiation into CD28+ T‑lymphocytes at the stage of immunity suppression in unfavourable viral infections.
Geroprotective and Anti‑Apoptotic Effects
The EW and KE peptides have a pronounced antiapoptotic effect in “young” and “old” cultures of blood lymphocytes. The antiapoptotic and geroprotective effect of peptides can be realised via activation of the transcription of apoptosis genes when the conformation of histones changes under the influence of short peptides. Thymalin reduces the level of receptor and mitochondrial apoptosis in blood lymphocytes during replicative aging.
Research Note: Clinical History and Regulatory Status
Thymalin was first approved for clinical use in the USSR in 1982 for immunodeficiency states and has remained in the Russian pharmacopeia since then (current registration LS‑000267). It has demonstrated efficacy in various infectious diseases (hepatitis A and B, erysipelas, meningococcal infection, typhoid fever), acute respiratory diseases, pneumonia of various origins, and cavernous pulmonary tuberculosis. Thymalin reduced the incidence of acute respiratory infections in senior patients 2.0–2.4‑fold. It is not approved by the FDA, EMA, or other Western regulatory agencies.
Key Research Applications for Thymalin (25mg)
Thymalin (25mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.
1. Immunology & T‑Cell Differentiation Research
Thymalin is widely utilised in immunological studies to elucidate the mechanisms governing T‑cell differentiation, maturation, and functional modulation. Research applications include:
-
T‑Cell Maturation Studies: Investigating how Thymalin activates the differentiation of human haematopoietic stem cells into CD28+ T‑lymphocytes.
-
Lymphocyte Subpopulation Analysis: Studying the restoration of the number and ratio of T‑ and B‑lymphocytes and their subpopulations.
-
Cellular Immunity Models: Exploring how Thymalin stimulates cellular immunity response and increases phagocytosis.
-
Immunodeficiency Research: Investigating Thymalin’s potential to restore immune function in models of immunodepression.
2. Geroprotection & Cellular Aging Research
Thymalin has demonstrated significant geroprotective efficacy in long‑term studies. Research has demonstrated:
-
Life Extension Studies: Long‑term observation of senior patients over 6‑8 years showed that Thymalin reduced mortality 2.0–2.1‑fold and reduced the incidence of acute respiratory infections 2.0–2.4‑fold.
-
Age‑Related Pathology Prevention: The high geroprotective efficacy of Thymalin supports its application in health maintenance and age‑related pathology prevention in persons over 60 to prolong active longevity.
-
Cellular Senescence Models: Investigating how Thymalin reduces receptor and mitochondrial apoptosis in blood lymphocytes during replicative aging.
3. Infectious Disease & Antiviral Research
Thymalin has demonstrated efficacy in various infectious disease models:
-
Viral Infections: Thymalin is effective in hepatitis A and B, erysipelas, meningococcal infection, typhoid fever, and acute respiratory diseases.
-
COVID‑19 Models: In a clinical study of severe COVID‑19 in older patients, Thymalin administered against standard therapy manifested more rapid clinical improvement, faster recovery from lymphopenia, and halved hospital mortality.
-
Respiratory Research: Thymalin has demonstrated efficacy in acute respiratory distress syndrome and chronic obstructive pulmonary disease.
4. Haematopoiesis & Stem Cell Research
Thymalin facilitates the processes of regeneration and haematopoiesis in cases of suppression. Research applications include:
-
Hematopoietic Stem Cell Differentiation: Investigating how Thymalin activates HSC differentiation into CD28+ T‑lymphocytes.
-
Bone Marrow Recovery Models: Studying Thymalin’s potential to support haematopoiesis after chemical and radiotherapy.
-
Haematological Research: Exploring the effects of Thymalin on haematopoiesis and regeneration.
5. Cytokine & Inflammatory Signalling Research
Thymalin prevents the “cytokine storm” by reducing the concentration of pro‑inflammatory cytokines including IL‑1α, IL‑6, IL‑8, and TNF‑α in the blood. Research applications include:
-
Cytokine Storm Models: Investigating how Thymalin regulates inflammatory responses.
-
Macrophage Research: Thymalin acts on macrophages as an anti‑inflammatory molecule during inflammatory and microbial‑mediated activity.
-
Heat‑Shock Protein Studies: Investigating how Thymalin regulates the synthesis of heat‑shock proteins.
Chemical & Physical Specifications for Thymalin (25mg)
Accurate characterisation of Thymalin (25mg) research peptide is essential for reproducible experimental design.
| Parameter | Specification |
|---|---|
| Common Names | Thymalin, Thymalin®, Thymic Factor, EW dipeptide complex, Thymogen precursor |
| Type | Polypeptide complex (thymic extract) containing dipeptides EW, KE, and tripeptide EDP |
| Key Active Component | L‑Glu‑L‑Trp (EW dipeptide); MW 333.34 g/mol; C₁₆H₁₉N₃O₅ |
| Source | Bovine calf thymus gland extract |
| Molecular Weight Range | 1,000 – 10,000 Da (polypeptide mixture) |
| Appearance | White to off‑white lyophilised powder |
| Solubility | Soluble in sterile water and 0.9% sodium chloride solution |
| Storage (Lyophilised) | –20°C, sealed, protected from light; stable for up to 2 years |
| Storage (Reconstituted) | 2‑8°C for up to 28 days; single‑use aliquots at –20°C for up to 3 months |
Note: Thymalin is a multi‑component polypeptide complex rather than a single molecular entity. The 25 mg mass refers to the total polypeptide weight of the complex.
Reconstitution & Handling Protocol for Thymalin (25mg)
Proper reconstitution of Thymalin (25mg) research peptide is critical for maintaining the structural integrity and biological activity of its constituent peptides.
Step 1 – Preparation
-
Bring the sealed Thymalin vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.
-
Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.
Step 2 – Vial Sanitisation
-
Wipe the rubber stopper of the Thymalin vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.
Step 3 – Reconstitution
-
Draw your desired volume of diluent into a sterile syringe. A typical starting concentration is 25 mg per 2.5 mL of diluent, yielding a 10 mg/mL stock solution.
-
Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.
-
Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously.
Step 4 – Aliquoting & Storage
-
Immediately after dissolution, aliquot the reconstituted Thymalin into single‑use sterile vials.
-
Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles.
-
Once thawed, store at 2‑8°C and use within 28 days.
Concentration Reference Table for Thymalin (25mg)
| Vial Mass | Diluent Volume | Final Concentration |
|---|---|---|
| 25 mg | 2.5 mL | 10 mg/mL |
| 25 mg | 5.0 mL | 5 mg/mL |
| 25 mg | 1.25 mL | 20 mg/mL |
Adjust diluent volume based on your experimental requirements.
Storage & Stability Guidelines for Thymalin (25mg)
| Storage Condition | Shelf Life | Notes |
|---|---|---|
| Lyophilised at –20°C, unopened | 2 years | Use desiccant, protect from light |
| Lyophilised at 2‑8°C, unopened | 6‑12 months | –20°C storage strongly preferred for long‑term stability |
| Reconstituted at 2‑8°C | Up to 28 days | Must be sterile; use aseptic technique for each withdrawal |
| Reconstituted aliquots at –20°C | Up to 3 months | Single freeze only; discard after thawing |
Why Choose Chinese Grey Peptides for Thymalin (25mg)?
As an authentic licensed peptide supplier based in the USA, we supply Thymalin (25mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).
-
Verified Quality: High‑purity polypeptide complex with batch‑to‑batch consistency.
-
GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.
-
Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.
-
Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.
-
USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade reagents for laboratory use only (RUO). Thymalin is not approved by the FDA, EMA, or other Western regulatory agencies.
Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.
FAQ: Thymalin (25mg) Research Peptide
What is Thymalin (25mg) research peptide?
Thymalin is a polypeptide complex isolated from the thymus gland of young calves, developed in the 1970s by Vladimir Khavinson and Vyacheslav Morozov. It contains three principal bioactive components: the dipeptides EW (Thymogen) and KE (Vilon), and the tripeptide EDP (Crystagen). It is used in research to study immunomodulation, T‑cell differentiation, geroprotection, and haematopoietic stem cell activation.
What are the key active components of Thymalin?
The three principal active components are: EW (Glu‑Trp / Thymogen) — activates T‑cell differentiation; KE (Lys‑Glu / Vilon) — stimulates cellular immunity; and EDP (Glu‑Asp‑Pro / Crystagen) — regulates gene expression and apoptosis.
What are the primary research applications for Thymalin?
Thymalin is used in immunology and T‑cell differentiation research, geroprotection and cellular aging studies, infectious disease and antiviral research (including COVID‑19 models), haematopoiesis and stem cell research, and cytokine and inflammatory signalling research.
How does Thymalin work?
Thymalin acts epigenetically by binding to certain DNA sequences and histone proteins, regulating gene expression and the synthesis of proteins involved in immunogenesis, heat‑shock proteins, cytokines, and gerontogenes. It normalises T‑ and B‑lymphocyte ratios, stimulates cellular immunity, and reduces apoptosis.
What clinical evidence supports Thymalin’s efficacy?
Thymalin has been shown to reduce mortality in senior patients 2.0–2.1‑fold over long‑term observation. In severe COVID‑19, Thymalin administration halved hospital mortality in older patients. It reduced the incidence of acute respiratory infections 2.0–2.4‑fold in senior patients.
What purity does your Thymalin (25mg) meet?
Our Thymalin is a high‑purity polypeptide complex with HPLC‑verified quality. A Certificate of Analysis (COA) is supplied with every order.
How should I reconstitute Thymalin (25mg)?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.
How should I store reconstituted Thymalin?
Reconstituted Thymalin should be stored at 2‑8°C and used within 28 days. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.
Is Thymalin research peptide legal to purchase in the USA?
Yes. Thymalin is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic claims. Note: Thymalin is not approved by the FDA, EMA, or other Western regulatory agencies.
Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.
Thymalin (25mg)
- Shop Page
- Bulk Orders Page
- Contact Page
- Shipping & Return Page
- Peptide Purity Page
- PMC Thymalin review
- PubMed Thymalin stem-cell paper
- PubMed thymus peptide preparation reference
- FDA peptide warning letter
- Google ecommerce product data guidance
- Rank Math WooCommerce Product Schema
Ships to USA, Canada, UK & Europe
Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.
Shipping support may include:
- Order processing updates
- Packaging support
- Tracking information where available
- Wholesale shipment planning
- Destination-based shipping review
- Customer support during transit
Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.
Why Choose Chinese Grey Peptides?
Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.
Customers choose us for:
- Professional peptide supplier support
- Small and wholesale order options
- Product documentation support
- HPLC testing information where available
- Mass Spectrum documentation where available
- International shipping support
- Responsive communication
- Clear order assistance before payment
We aim to make the buying process transparent, professional, and documentation-focused.
Thymalin (25mg)
Important Compliance Notice
Thymalin 25mg may be regulated differently depending on the country, product type, labeling, intended use, and customer type. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, immune-support claims, anti-aging claims, longevity claims, disease claims, treatment claims, recovery claims, performance claims, or personal-use recommendations.
Customers are responsible for understanding and following all local laws, import rules, prescription requirements, and permitted-use requirements before ordering.
From its discovery as the first peptide bioregulator to its well‑characterised role in epigenetically regulating gene expression, modulating T‑cell differentiation, and activating haematopoietic stem cells, Thymalin (25mg) research peptide provides a precisely defined and extensively validated platform for advanced immunological and gerontological research. Its ability to normalise lymphocyte ratios, reduce apoptosis, and restore immune function—supported by decades of peer‑reviewed research published in Advances in Gerontology, Biology Bulletin Reviews, and other authoritative journals—makes it a valuable addition to any laboratory investigating immunology, stem cell biology, geroprotection, or infectious disease models. By choosing high‑purity, lab‑verified Thymalin (25mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.
Ready to advance your research with Thymalin (25mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade Thymalin delivered directly to your facility in the USA, UK, or Europe.




Reviews
There are no reviews yet.